These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 15886824)

  • 1. Rituximab in the treatment of factor XIII inhibitor possibly caused by Ciprofloxacin.
    Miesbach W
    Thromb Haemost; 2005 May; 93(5):1001-3. PubMed ID: 15886824
    [No Abstract]   [Full Text] [Related]  

  • 2. Efficacy of rituximab in acquired factor XIII inhibitor after arterial rFVIIa-induced thrombosis.
    Ngo Sack F; Galinat H; Egreteau PY; Mollard LM; Fortin H; Berthou C; Abgrall JF; Pan-Petesch B
    Haemophilia; 2013 Mar; 19(2):e93-4. PubMed ID: 23205641
    [No Abstract]   [Full Text] [Related]  

  • 3. Acquired factor XIII deficiency: a therapeutic challenge.
    Boehlen F; Casini A; Chizzolini C; Mansouri B; Kohler HP; Schroeder V; Reber G; de Moerloose P
    Thromb Haemost; 2013 Mar; 109(3):479-87. PubMed ID: 23306660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful eradication of inhibitor in a patient with severe haemophilia B and anaphylaxis to factor IX concentrates: is there a role for Rituximab and desensitization therapy?
    Gamerman S; Singh AM; Makhija M; Sharathkumar A
    Haemophilia; 2013 Nov; 19(6):e382-5. PubMed ID: 23992223
    [No Abstract]   [Full Text] [Related]  

  • 5. Successful Management of a Patient with Autoimmune Hemorrhaphilia due to Anti-Factor XIII/13 Antibodies Complicated by Pulmonary Thromboembolism.
    Ogawa Y; Yanagisawa K; Souri M; Mihara M; Naito C; Takizawa M; Ishizaki T; Mitsui T; Handa H; Osaki T; Nojima Y; Ichinose A
    Acta Haematol; 2017; 137(3):141-147. PubMed ID: 28380473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autoimmune haemophilia in a teenager.
    Batra S; Sharathkumar A; Glaubach T; Gamerman S; Green D
    Haemophilia; 2013 Nov; 19(6):e386-8. PubMed ID: 23992250
    [No Abstract]   [Full Text] [Related]  

  • 7. [Acquired haemophilia: From registers' data to therapeutic recommendations].
    Lévesque H
    Rev Med Interne; 2013 Jan; 34(1):1-3. PubMed ID: 22998977
    [No Abstract]   [Full Text] [Related]  

  • 8. Severe bleeding complications caused by an autoantibody against the B subunit of plasma factor XIII: a novel form of acquired factor XIII deficiency.
    Ajzner E; Schlammadinger A; Kerényi A; Bereczky Z; Katona E; Haramura G; Boda Z; Muszbek L
    Blood; 2009 Jan; 113(3):723-5. PubMed ID: 18955560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Successful treatment of a patient with acquired haemophilia A with a combination of a low-dose rituximab and recombinant human FVIIa.
    Xu Y; Zhang X; Zhao Y; Zhao L; Qiu H; Wu D
    Haemophilia; 2013 Mar; 19(2):e95-6. PubMed ID: 23231056
    [No Abstract]   [Full Text] [Related]  

  • 10. Successful use of recombinant factor VIIa in a child with Schoenlein-Henoch purpura presenting with compartment syndrome and severe factor XIII deficiency.
    Alioglu B; Ozsoy MH; Tapci E; Karamercan S; Agras PI; Dallar Y
    Blood Coagul Fibrinolysis; 2013 Jan; 24(1):102-5. PubMed ID: 23103728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatment of acquired inhibitors of coagulation factors].
    Koyama T
    Rinsho Ketsueki; 2014 Jan; 55(1):67-74. PubMed ID: 24492039
    [No Abstract]   [Full Text] [Related]  

  • 12. In vitro inhibition of factor XIII retards clot formation, reduces clot firmness, and increases fibrinolytic effects in whole blood.
    Jámbor C; Reul V; Schnider TW; Degiacomi P; Metzner H; Korte WC
    Anesth Analg; 2009 Oct; 109(4):1023-8. PubMed ID: 19762725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Replacement therapy of coagulation factor preparations: antithrombin, FFP, PPSB, FXIII, rFVIIa].
    Scharrer I
    Hamostaseologie; 2005 May; 25(2):209-12. PubMed ID: 15924160
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factor X inhibitor: a fulminant presentation and fatal course of a rare syndrome in a 59-year-old male.
    Gollard R; Rahman S; Ratnasabapathy R
    Acta Haematol; 2013; 129(1):40-4. PubMed ID: 23107910
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Documentation of the plasma factor XIII deficiency in man.
    Duckert F
    Ann N Y Acad Sci; 1972 Dec; 202():190-9. PubMed ID: 4508922
    [No Abstract]   [Full Text] [Related]  

  • 16. [Massive bleeding symptoms in two patients with factor V inhibitor and antiphospholipid antibodies after treatment with ciprofloxacin].
    Miesbach W; Voigt J; Peetz D; Scharrer I
    Med Klin (Munich); 2003 Jun; 98(6):339-43. PubMed ID: 12811419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coagulation factor XIII deficiency. Diagnosis, prevalence and management of inherited and acquired forms.
    Biswas A; Ivaskevicius V; Thomas A; Oldenburg J
    Hamostaseologie; 2014; 34(2):160-6. PubMed ID: 24503678
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factor XIII deficiency: pathogenic mechanisms and clinical significance.
    Egbring R; Kröniger A; Seitz R
    Semin Thromb Hemost; 1996; 22(5):419-25. PubMed ID: 8989826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapid immunochromatographic test for detection of anti-factor XIII A subunit antibodies can diagnose 90 % of cases with autoimmune haemorrhaphilia XIII/13.
    Osaki T; Sugiyama D; Magari Y; Souri M; Ichinose A
    Thromb Haemost; 2015 Jun; 113(6):1347-56. PubMed ID: 25740658
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acquired factor XIII inhibitor in monoclonal gammopathy of undetermined significance: characterization and cross-linked fibrin ultrastructure.
    Luo Y; Zhang G; Zuo W; Zheng W; Dai C
    Ann Hematol; 2010 Aug; 89(8):833-4. PubMed ID: 19953252
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.